Diagnosing Insulin Resistance
The most effective way to diagnose insulin resistance is through a combination of clinical risk assessment and laboratory testing, including fasting plasma glucose, fasting insulin levels, oral glucose tolerance test, and hemoglobin A1C. 1
Clinical Risk Assessment
- Evaluate for risk factors that predispose to insulin resistance:
- Overweight or obesity (BMI ≥25 kg/m² or ≥23 kg/m² in Asian Americans) 1
- Family history of type 2 diabetes 1
- Racial/ethnic predisposition (American Indian, African American, Hispanic, or Asian/Pacific Islander) 1
- Physical signs including acanthosis nigricans (dark, velvety skin patches typically in body folds), hypertension, dyslipidemia, or polycystic ovary syndrome 1
Laboratory Diagnostic Tests
Primary Tests
Fasting plasma glucose (FPG):
Fasting plasma insulin levels:
- Normal: <15 mU/L
- Borderline high: 15-20 mU/L
- High: >20 mU/L (directly suggests insulin resistance) 1
Oral glucose tolerance test (OGTT):
Hemoglobin A1C:
Supplementary Tests
C-peptide measurement:
Lipid profile:
- Elevated triglycerides (>150 mg/dL) and low HDL cholesterol (<40 mg/dL in men, <50 mg/dL in women) often accompany insulin resistance 1
Calculation-Based Methods
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR):
TyG Index (Triglycerides-Glucose Index):
- Formula: Ln[fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]
- Can be useful when insulin testing is unavailable 5
Physical Examination
- Check for:
Common Pitfalls to Avoid
- Testing should be performed in the fasting state to avoid postprandial variations that can affect results 1
- Medications that affect glucose metabolism should be noted when interpreting results 1
- Stress hyperglycemia during acute illness can temporarily mimic insulin resistance and should not be used for diagnosis 1
- Isolated elevated C-peptide without hypoglycemia generally reflects insulin resistance rather than pathological hyperinsulinism 1
- Relying on a single test without confirmation can lead to misdiagnosis 2
Diagnostic Algorithm
- Identify patients with risk factors for insulin resistance
- Perform fasting laboratory tests (glucose, insulin, lipid profile)
- If fasting glucose is 100-125 mg/dL or fasting insulin is >15 mU/L, insulin resistance is likely 1
- Consider OGTT if fasting tests are borderline or normal but clinical suspicion remains high 1
- Calculate HOMA-IR if both fasting glucose and insulin are available 3, 4
- If insulin testing is unavailable, consider using the TyG index as an alternative 5